The impact of misclassification errors on the performance of biomarkers based on next-generation sequencing, a simulation study.
Saved in:
| Title: | The impact of misclassification errors on the performance of biomarkers based on next-generation sequencing, a simulation study. |
|---|---|
| Authors: | Wang D; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA., Wang SJ; Office of Biostatistics, Center for Drug Evaluation Research, FDA, Maryland, USA., Lababidi S; Office of Data, Analytics and Research, Office of Digital Transformation, Office of Commissioner, FDA, Maryland, USA. |
| Source: | Journal of biopharmaceutical statistics [J Biopharm Stat] 2024 Aug; Vol. 34 (5), pp. 700-718. Date of Electronic Publication: 2023 Oct 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5711 (Electronic) Linking ISSN: 10543406 NLM ISO Abbreviation: J Biopharm Stat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1520-5711 |
|---|---|
| DOI: | 10.1080/10543406.2023.2269251 |
